ZA965205B - Process for optical purification of compounds - Google Patents
Process for optical purification of compoundsInfo
- Publication number
- ZA965205B ZA965205B ZA965205A ZA965205A ZA965205B ZA 965205 B ZA965205 B ZA 965205B ZA 965205 A ZA965205 A ZA 965205A ZA 965205 A ZA965205 A ZA 965205A ZA 965205 B ZA965205 B ZA 965205B
- Authority
- ZA
- South Africa
- Prior art keywords
- compounds
- optical purification
- purification
- optical
- sulphinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9500817 | 1995-07-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA965205B true ZA965205B (en) | 1997-01-03 |
Family
ID=20397468
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA965205A ZA965205B (en) | 1995-07-03 | 1996-06-19 | Process for optical purification of compounds |
Country Status (37)
Country | Link |
---|---|
US (1) | US5929244A (fr) |
EP (2) | EP1498416A1 (fr) |
JP (1) | JP4195507B2 (fr) |
KR (1) | KR100451078B1 (fr) |
CN (1) | CN1098261C (fr) |
AT (1) | ATE418549T1 (fr) |
AU (1) | AU698638B2 (fr) |
BR (1) | BR9609450A (fr) |
CA (1) | CA2226184C (fr) |
CZ (1) | CZ295430B6 (fr) |
DE (1) | DE69637788D1 (fr) |
DK (1) | DK0836601T3 (fr) |
DZ (1) | DZ2057A1 (fr) |
EE (1) | EE03444B1 (fr) |
ES (1) | ES2318850T3 (fr) |
HK (1) | HK1010193A1 (fr) |
HR (1) | HRP960232A2 (fr) |
HU (1) | HUP9901717A3 (fr) |
IL (1) | IL122811A (fr) |
IS (1) | IS2666B (fr) |
MA (1) | MA23921A1 (fr) |
MY (1) | MY114018A (fr) |
NO (1) | NO313008B1 (fr) |
NZ (1) | NZ311842A (fr) |
PL (1) | PL186702B1 (fr) |
PT (1) | PT836601E (fr) |
RS (1) | RS49826B (fr) |
RU (1) | RU2144031C1 (fr) |
SA (1) | SA96170103B1 (fr) |
SI (1) | SI0836601T1 (fr) |
SK (1) | SK284780B6 (fr) |
TN (1) | TNSN96090A1 (fr) |
TR (1) | TR199701754T1 (fr) |
TW (1) | TW444010B (fr) |
UA (1) | UA49838C2 (fr) |
WO (1) | WO1997002261A1 (fr) |
ZA (1) | ZA965205B (fr) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HRP960232A2 (en) * | 1995-07-03 | 1998-02-28 | Astra Ab | A process for the optical purification of compounds |
US6699885B2 (en) * | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6051570A (en) * | 1997-05-30 | 2000-04-18 | Dr. Reddy's Research Foundation | Benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them |
JP2002501897A (ja) * | 1998-01-30 | 2002-01-22 | セプラコール, インク. | R−ランソプラゾール組成物及び方法 |
SE9900274D0 (sv) | 1999-01-28 | 1999-01-28 | Astra Ab | New compound |
TWI275587B (en) | 1999-06-17 | 2007-03-11 | Takeda Chemical Industries Ltd | A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole |
EP1191025B1 (fr) | 1999-06-30 | 2005-06-22 | Takeda Pharmaceutical Company Limited | Cristaux de lansoprazole |
US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
US6326384B1 (en) | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6780880B1 (en) | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
ES2511774T3 (es) * | 2000-05-15 | 2014-10-23 | Takeda Pharmaceutical Company Limited | Formas cristalinas de (R)-lansoprazol |
CA2417311C (fr) | 2000-08-04 | 2012-07-10 | Takeda Chemical Industries, Ltd. | Sels cristallins de metal alcalin et de lansoprazole et methode de production et utilisation connexes |
TWI290922B (en) | 2000-12-01 | 2007-12-11 | Takeda Chemical Industries Ltd | Production method of crystals |
KR100433735B1 (ko) * | 2001-06-27 | 2004-06-04 | 주식회사 씨트리 | 결정형 ⅰ을 갖는 란소프라졸의 제조방법 |
SE0104295D0 (sv) * | 2001-12-18 | 2001-12-18 | Astrazeneca Ab | New process |
EP1469839A2 (fr) * | 2002-01-25 | 2004-10-27 | Santarus, Inc. | Administration par voie muqueuse d'inhibiteurs de la pompe a protons |
EP2596792A1 (fr) | 2002-10-16 | 2013-05-29 | Takeda Pharmaceutical Company Limited | Préparations solides stables |
MY148805A (en) | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
DE10254167A1 (de) | 2002-11-20 | 2004-06-09 | Icon Genetics Ag | Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen |
SI1575941T1 (sl) | 2002-12-06 | 2012-08-31 | Nycomed Gmbh | Postopek za pripravo (S)-pantoprazola |
CA2507807C (fr) | 2002-12-06 | 2013-10-22 | Altana Pharma Ag | Procede de preparation de composes actifs optiquement purs inhibiteurs de la pompe a protons |
JP2006518751A (ja) * | 2003-02-20 | 2006-08-17 | サンタラス インコーポレイティッド | 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物 |
RU2005129513A (ru) * | 2003-02-28 | 2006-03-10 | Рэнбакси Лабораториз Лимитед (In) | Полиморфы s-омепразола |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
TWI337877B (en) * | 2003-07-18 | 2011-03-01 | Santarus Inc | Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders |
US7005732B2 (en) * | 2003-10-21 | 2006-02-28 | Honeywell International Inc. | Methods and systems for providing MEMS devices with a top cap and upper sense plate |
FR2863609A1 (fr) * | 2003-12-15 | 2005-06-17 | Isochem Sa | Procede d'enrichissement enantiomerique d'un melange d'enantiomeres d'alpha-aminoacides |
SE0400410D0 (sv) * | 2004-02-20 | 2004-02-20 | Astrazeneca Ab | New compounds |
US8815916B2 (en) * | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) * | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
CA2570916C (fr) | 2004-06-16 | 2013-06-11 | Tap Pharmaceutical Products, Inc. | Forme posologique d'ipp a doses multiples |
EP1801110A1 (fr) | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Sel d'arginine d'ésoméprazole |
US7553857B2 (en) | 2005-12-23 | 2009-06-30 | Lek Pharmaceuticals D.D. | S-omeprazole magnesium |
US7786309B2 (en) * | 2006-06-09 | 2010-08-31 | Apotex Pharmachem Inc. | Process for the preparation of esomeprazole and salts thereof |
FR2909380B1 (fr) * | 2006-12-04 | 2009-02-20 | Sidem Pharma Sa Sa | Conglomerats de sels de potassium de tenatoprazole |
EP1947099A1 (fr) | 2007-01-18 | 2008-07-23 | LEK Pharmaceuticals D.D. | Procédé pour l'élimination de solvant des sels d'oméprazole |
BRPI0813191B1 (pt) * | 2007-06-15 | 2021-09-08 | Emcure Pharmaceuticals Limited | Processo de sulfoxidação de compostos biologicamente ativos |
CN101323609B (zh) * | 2007-06-15 | 2013-05-01 | 成都福瑞生物工程有限公司 | 不对称氧化硫醚成亚砜合成对映体含量高的苯并咪唑衍生物的方法 |
FR2920428B1 (fr) * | 2007-08-29 | 2012-06-15 | Univ Rouen | Procede de dedoublement de sels de l'omeprazole |
JP2011513202A (ja) | 2008-03-10 | 2011-04-28 | 武田薬品工業株式会社 | ベンズイミダゾール化合物の結晶 |
WO2010058409A2 (fr) | 2008-11-18 | 2010-05-27 | Hetero Research Foundation | Purification optique d'esoméprazole |
KR101001646B1 (ko) * | 2008-12-12 | 2010-12-17 | 한미약품 주식회사 | (r)-(+)-란소프라졸의 제조방법 및 이에 사용되는 중간체 |
WO2011004387A2 (fr) | 2009-06-18 | 2011-01-13 | Matrix Laboratories Ltd | Procédé de préparation de formes polymorphes du dexlansoprazole |
WO2011058569A1 (fr) | 2009-11-12 | 2011-05-19 | Hetero Research Foundation | Procédé de dédoublement de l'oméprazole |
CA2788147A1 (fr) | 2010-01-29 | 2011-08-04 | Ranbaxy Laboratories Limited | Procede pour la preparation de formes cristallines de dexlansoprazole |
KR102091211B1 (ko) * | 2014-07-30 | 2020-03-19 | 가부시키가이샤 아에타스 파루마 | 1,4-벤조티아제핀-1-옥사이드 유도체의 광학 이성질체, 및 그것을 사용한 의약 조성물 |
ES2615637T3 (es) * | 2015-03-06 | 2017-06-07 | F.I.S.- Fabbrica Italiana Sintetici S.P.A. | Procedimiento mejorado para la purificación óptica del esomeprazol |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
JPS6150978A (ja) * | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
AU4640985A (en) * | 1984-08-31 | 1986-03-06 | Nippon Chemiphar Co. Ltd. | Benzimidazole derivatives |
FI90544C (fi) * | 1986-11-13 | 1994-02-25 | Eisai Co Ltd | Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi |
DE69011645T2 (de) * | 1989-11-29 | 1995-01-12 | Toa Eiyo Ltd | Cycloheptenopyridinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Antiulkusmitteln. |
DE4035455A1 (de) * | 1990-11-08 | 1992-05-14 | Byk Gulden Lomberg Chem Fab | Enantiomerentrennung |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
IS4232A (is) * | 1993-12-06 | 1995-06-07 | Astra Aktiebolag | Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun |
HRP960232A2 (en) * | 1995-07-03 | 1998-02-28 | Astra Ab | A process for the optical purification of compounds |
-
1996
- 1996-05-21 HR HRPCT/SE95/00817A patent/HRP960232A2/hr not_active Application Discontinuation
- 1996-06-19 SA SA96170103A patent/SA96170103B1/ar unknown
- 1996-06-19 ZA ZA965205A patent/ZA965205B/xx unknown
- 1996-06-19 RS YUP-376/96A patent/RS49826B/sr unknown
- 1996-06-22 TW TW085107517A patent/TW444010B/zh not_active IP Right Cessation
- 1996-06-26 DE DE69637788T patent/DE69637788D1/de not_active Expired - Lifetime
- 1996-06-26 DZ DZ960101A patent/DZ2057A1/fr active
- 1996-06-26 CN CN96196465A patent/CN1098261C/zh not_active Expired - Lifetime
- 1996-06-26 EP EP04024339A patent/EP1498416A1/fr not_active Withdrawn
- 1996-06-26 JP JP50506397A patent/JP4195507B2/ja not_active Expired - Lifetime
- 1996-06-26 EP EP96922339A patent/EP0836601B1/fr not_active Expired - Lifetime
- 1996-06-26 US US08/676,215 patent/US5929244A/en not_active Expired - Lifetime
- 1996-06-26 BR BR9609450A patent/BR9609450A/pt not_active Application Discontinuation
- 1996-06-26 WO PCT/SE1996/000841 patent/WO1997002261A1/fr active IP Right Grant
- 1996-06-26 IL IL12281196A patent/IL122811A/xx not_active IP Right Cessation
- 1996-06-26 HU HU9901717A patent/HUP9901717A3/hu not_active Application Discontinuation
- 1996-06-26 SI SI9630766T patent/SI0836601T1/sl unknown
- 1996-06-26 PL PL96324394A patent/PL186702B1/pl not_active IP Right Cessation
- 1996-06-26 ES ES96922339T patent/ES2318850T3/es not_active Expired - Lifetime
- 1996-06-26 SK SK1793-97A patent/SK284780B6/sk not_active IP Right Cessation
- 1996-06-26 KR KR1019970709953A patent/KR100451078B1/ko not_active IP Right Cessation
- 1996-06-26 DK DK96922339T patent/DK0836601T3/da active
- 1996-06-26 AT AT96922339T patent/ATE418549T1/de active
- 1996-06-26 EE EE9700368A patent/EE03444B1/xx not_active IP Right Cessation
- 1996-06-26 TR TR97/01754T patent/TR199701754T1/xx unknown
- 1996-06-26 NZ NZ311842A patent/NZ311842A/xx not_active IP Right Cessation
- 1996-06-26 AU AU63240/96A patent/AU698638B2/en not_active Expired
- 1996-06-26 RU RU98101727A patent/RU2144031C1/ru not_active IP Right Cessation
- 1996-06-26 UA UA97126300A patent/UA49838C2/uk unknown
- 1996-06-26 CA CA002226184A patent/CA2226184C/fr not_active Expired - Lifetime
- 1996-06-26 PT PT96922339T patent/PT836601E/pt unknown
- 1996-06-26 CZ CZ19974211A patent/CZ295430B6/cs not_active IP Right Cessation
- 1996-06-28 MA MA24295A patent/MA23921A1/fr unknown
- 1996-07-02 TN TNPCT/SE1995/000817A patent/TNSN96090A1/fr unknown
- 1996-07-03 MY MYPI96002734A patent/MY114018A/en unknown
-
1997
- 1997-01-21 IS IS4638A patent/IS2666B/is unknown
- 1997-12-22 NO NO19976030A patent/NO313008B1/no not_active IP Right Cessation
-
1998
- 1998-09-26 HK HK98110996.6A patent/HK1010193A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA965205B (en) | Process for optical purification of compounds | |
AU7062496A (en) | Process for the production of Bis(silyalkyl)-disulfanes | |
EP0764673A3 (fr) | Procédé de préparation de polycarbonate | |
DE69623429T2 (de) | Verfahren zur kontinuierlichen Herstellung von aromatischen Carbonaten | |
HUP9900110A3 (en) | Novel process for the synthesis of omeprazole | |
IL124645A0 (en) | Process for the production of 1, 2-bis (acyloxylates) | |
GR3032600T3 (en) | Process for the production of imidazo-benzodiazepine derivatives | |
SG52815A1 (en) | Process for the production of phenol | |
FR2708266B1 (fr) | Procédé de préparation d'alcanesulfonamides. | |
EE03393B1 (et) | Protsess enantiomeerselt puhta asetidiin-2-karboksüülhappe saamiseks | |
ZA963132B (en) | Process for the preparation of pure enantiomers of 1-2-pyridyl)-2-cyclo-hexylethylamine. | |
DE69610747T2 (de) | Verfahren zur Herstellung von hochreinem 2,4'-Dihydroxydiphenylsulfon | |
AU7639994A (en) | Process for the separation of enantiomers | |
HRP931019A2 (en) | Enzymatic process for separation of delta-valerolactone racemic mixtures | |
FR2708928B1 (fr) | Procédé de préparation de 2-halogéno-éthyl-malonates de dialkyle. | |
EP0728722A3 (fr) | Procédé pour la production d'hydroxyméthylcyclopropane | |
FR2721312B1 (fr) | Procédé de fabrication d'halogénoalcanols. | |
EP0728723A3 (fr) | Procédé pour la production de fluorènebisphénol | |
FR2717475B1 (fr) | Procédé de préparation d'aryltétrazoles. | |
EP0490407A3 (en) | Process for the enzymatic separation of the optical isomers of tosyloxy-alkanols | |
EP0461531A3 (en) | Process for the purification of 2-chloro-5-nitrobenzaldehyde or their acetals | |
ZA965169B (en) | Process for the production of enantiomerically-pure azeti-dine-2-carboxylic acid | |
HU9203625D0 (en) | Stereoselective process for producing optical isomers of 1-benzoyl-4-hydroxi-5-(1-phenyl-ethyl)-amino-1,2,2a,3,4,5-hexahydrobenz/cd/-indole |